2019
Chapter 53 Transfusion Management of Patients Undergoing Hematopoietic Stem Cell and Solid Organ Transplantation
Rutter S, Hendrickson J. Chapter 53 Transfusion Management of Patients Undergoing Hematopoietic Stem Cell and Solid Organ Transplantation. 2019, 337-341. DOI: 10.1016/b978-0-12-813726-0.00053-2.Peer-Reviewed Original ResearchSolid organ transplantationOrgan transplantationHematopoietic stem cellsOptimal transfusion triggerTransfusion adverse eventsBlood product selectionStem cellsGranulocyte transfusionsAdverse eventsPlatelet refractorinessTransfusion supportTransfusion triggerTransfusion managementTransplant servicesRhD typeOptimal outcomesTransfusionPatientsTransplantationCellsRecipientsRefractorinessChapter 57 Platelet Transfusion Refractory Patients
Tormey C, Hendrickson J. Chapter 57 Platelet Transfusion Refractory Patients. 2019, 361-364. DOI: 10.1016/b978-0-12-813726-0.00057-x.ChaptersHuman leukocyte antigenPlatelet refractorinessRefractory patientsPlatelet transfusion-refractory patientsRecipient human leukocyte antigenClass I human leukocyte antigenPlatelet refractory patientsPlatelet transfusion supportManagement of patientsHLA-B antigensCauses of refractorinessHLA alloantibodiesNonimmune causesHost diseaseTransfusion supportLeukocyte antigenOptimal carePatientsClinical teamTransfusion servicesMultidisciplinary approachRefractorinessBlood suppliersPlateletsAntigen
2013
Chapter 55 Platelet Transfusion Refractory Patients
Hendrickson J. Chapter 55 Platelet Transfusion Refractory Patients. 2013, 361-365. DOI: 10.1016/b978-0-12-397164-7.00055-0.Peer-Reviewed Original Research
2009
Chapter 49 Platelet Transfusion Refractory Patients
Hendrickson J, Roback J. Chapter 49 Platelet Transfusion Refractory Patients. 2009, 283-286. DOI: 10.1016/b978-0-12-374432-6.00049-x.Peer-Reviewed Original ResearchPlatelet refractory patientsHost diseaseRefractory patientsPlatelet refractoryAntibody detectionHuman leukocyte antigen alloimmunizationPlatelet transfusion-refractory patientsNon-immune causesTransfusion-associated graftLow platelet countHLA antibody detectionImmune causesImmunosuppressive medicationsPlatelet crossmatchingPlatelet refractorinessHLA antigensPlasma exchangePlatelet transfusionsPlatelet countPotential therapyPatientsTransfusionMedicationsGraftPlateletsChapter 46 Transfusion of Patients Undergoing HPC and Solid-organ Transplantation
Hendrickson J, Roback J. Chapter 46 Transfusion of Patients Undergoing HPC and Solid-organ Transplantation. 2009, 269-274. DOI: 10.1016/b978-0-12-374432-6.00046-4.Peer-Reviewed Original ResearchRed blood cellsTransfusion requirementsPlatelet transfusionsBlood productsFebrile non-hemolytic transfusion reactionsNon-hemolytic transfusion reactionsHematopoietic progenitor cell transplantationNon-myeloablative transplantsPreparative conditioning regimenRisk of transfusionSolid organ transplantationType of transplantProgenitor cell transplantationCategory of patientsTransfusion of bloodBlood product selectionFuture platelet transfusionABO mismatchMyeloablative transplantsConditioning regimenTransplant recipientsHLA alloimmunizationTransfusion triggerPlatelet refractorinessCell transplantation